Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Andrographolide for blood pressure and endothelial function in hypertension
ChiCTR2300071970Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of andrographolide in hypertension (HTN) (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: brachial-ankle pulse wave velocity and flow-mediated vasodilatation. Started Jan 2023; status: recruiting.
02
Drugs
andrographolide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2300071970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071970.